Liver-cell adenomas associated with use of oral contraceptives

N Engl J Med. 1976 Feb 26;294(9):470-2. doi: 10.1056/NEJM197602262940904.

Abstract

During the past six years an increasing number of liver-cell adenomas in women were diagnosed, and we undertook a study of possible etiologic factors, including use of oral contraceptives, in 42 women. There was a significant difference between cases and matched controls in mean months of oral-contraceptive use: 73.4 as compared to 36.2 (P less than 0.001). The women with adenomas took mestranol-containing pills much more commonly than the controls (P less than 0.0001). Hemorrhage into the tumor was often associated with the onset of menstruation in women taking oral contraceptives. Long-term use of oral contraceptives, especially those containing a high total dose of steroids or mestranol as the synthetic estrogen, should be balanced against risks of side effects of the drugs.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Carcinoma, Hepatocellular / chemically induced*
  • Carcinoma, Hepatocellular / pathology
  • Contraceptives, Oral / adverse effects*
  • Ethinyl Estradiol / adverse effects
  • Female
  • Humans
  • Liver / pathology
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / pathology
  • Mestranol / adverse effects
  • Middle Aged
  • Risk
  • Time Factors

Substances

  • Contraceptives, Oral
  • Ethinyl Estradiol
  • Mestranol